Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:Editorial (Hot Topic: Mitochondrion: An Organelle More and More Implication in New Processes)
Volume: 7 Issue: 2
Author(s): Ana Coto-Montes
Affiliation:
Export Options
About this article
Cite this article as:
Coto-Montes Ana, Editorial (Hot Topic: Mitochondrion: An Organelle More and More Implication in New Processes), Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2013; 7 (2) . https://dx.doi.org/10.2174/1872214811307020001
DOI https://dx.doi.org/10.2174/1872214811307020001 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
16
Related Articles
-
Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Mouse In Cancer Research Past, Present, Future
Current Genomics The Long Term Biological Consequences of Anorexia Nervosa
Current Nutrition & Food Science The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy
Current Drug Targets On the Future Development of Optimally-Sized Lipid-Insoluble Systemic Therapies for CNS Solid Tumors and Other Neuropathologies
Recent Patents on CNS Drug Discovery (Discontinued) Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
Current Medicinal Chemistry Medicinal Agents and Metabolic Syndrome
Current Medicinal Chemistry New Insights into the Molecular Mechanisms of Corticosteroids Actions
Current Drug Targets Recent Advances in Pharmacological Interventions of Chronic Prostatitis/ Chronic Pelvic Pain Syndrome
Current Pharmaceutical Design Disruption of Circadian Rhythms and Sleep in Critical Illness: Potential Implications for Angiogenesis After Myocardial Infarction. A Review
Current Pharmaceutical Design Energy Balance and Carcinogenesis: Underlying Pathways and Targets for Intervention
Current Cancer Drug Targets Fine-tuning of microRNAs in Type 2 Diabetes Mellitus
Current Medicinal Chemistry Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders
Current Molecular Medicine Diabetes and Pancreas: Why So Difficult? Potential Mechanisms of Elevated Serum Pancreatic Enzymes
Current Medicinal Chemistry Synergic Study of α-Glucosidase Inhibitory Action of Aloin and its Antioxidant Activity with and without Camel β-Casein and its Peptides
Protein & Peptide Letters Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
Current Pharmaceutical Design Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
Current Signal Transduction Therapy Subject Index To Volume 6
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunotherapy for Malignant Melanoma Robert
Current Stem Cell Research & Therapy